Myc-Luc/EF1α-mCherry Reporter Cell Line - HepG2

HepG2 is a widely utilized human hepatoblastoma-derived cell line, favored in metabolic and toxicological studies for its epithelial-like growth and retention of various liver-specific protein expressions. The Myc-Luc/EF1α-mCherry Reporter HepG2 cell line is a stable derivative engineered to quantitatively monitor the activity of the c-Myc oncogene, a master regulator of cell growth, protein synthesis, and metabolism. This dual-reporter system incorporates a firefly luciferase gene under the control of multiple Myc-responsive elements, alongside a constitutively expressed mCherry fluorescent protein driven by the elongation factor 1-alpha (EF1α) promoter. By providing a bioluminescent readout proportional to c-Myc transcriptional output, paired with a stable red fluorescent signal for normalization, this cell line offers a sensitive and reliable platform for studying Myc-driven signaling within a hepatic cellular context.

This reporter line is primarily designed for high-throughput screening of therapeutic agents and small molecules aimed at inhibiting c-Myc, which is a major driver in the progression of various malignancies, including liver cancer. The inclusion of the EF1α-mCherry cassette allows for real-time monitoring of cell viability and serves as a crucial internal control to correct for variations in cell number or assay-induced toxicity. Researchers utilize this system to investigate the regulatory mechanisms of the Myc pathway, assess the impact of gene silencing or overexpression, and perform longitudinal studies via live-cell imaging. Its high sensitivity and broad dynamic range make it particularly suitable for validating the potency of lead compounds in drug development pipelines and for exploring the complex crosstalk between metabolic pathways and oncogenic transformation in liver-related diseases.